Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Common Equity (2016 - 2025)

Historic Common Equity for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to $5.6 million.

  • Creative Medical Technology Holdings' Common Equity fell 1472.26% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 1472.26%. This contributed to the annual value of $6.3 million for FY2024, which is 3869.27% down from last year.
  • Per Creative Medical Technology Holdings' latest filing, its Common Equity stood at $5.6 million for Q3 2025, which was down 1472.26% from $6.8 million recorded in Q2 2025.
  • Over the past 5 years, Creative Medical Technology Holdings' Common Equity peaked at $23.0 million during Q2 2022, and registered a low of -$2.4 million during Q1 2021.
  • In the last 5 years, Creative Medical Technology Holdings' Common Equity had a median value of $9.2 million in 2024 and averaged $9.4 million.
  • In the last 5 years, Creative Medical Technology Holdings' Common Equity soared by 617444.83% in 2022 and then tumbled by 4577.57% in 2024.
  • Over the past 5 years, Creative Medical Technology Holdings' Common Equity (Quarter) stood at $10.2 million in 2021, then surged by 55.27% to $15.9 million in 2022, then plummeted by 34.8% to $10.3 million in 2023, then crashed by 38.69% to $6.3 million in 2024, then dropped by 11.82% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $6.8 million for Q2 2025, and $8.1 million during Q1 2025.